---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-283722"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:47:29.026098+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology merges with Inmagene; Inmagene shareholders to own 55.6% of combined co.

## Summary
- Pre-PIPE, Inmagene shareholders own ~55.6%, Ikena ~44.4% of combined company.
- PIPE financing of $75M from accredited investors, closing simultaneously with merger.
- Loan agreement: Ikena to lend Inmagene up to $22.5M (initial $7.5M) secured by IMG-007 asset.
- Ikena stockholders to receive CVRs for potential proceeds from pre-merger assets (e.g., IK-595).
- Combined company board: 7 members, 3 from Inmagene, 2 from Ikena, 1 mutual, 1 from PIPE lead.

## SEC filing metadata
- accession: 0001193125-24-283722
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 5.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312524283722/0001193125-24-283722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312524283722/d889670d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-283722
- JSON: https://secwatch.observer/filing/0001193125-24-283722.json
- Plain text: https://secwatch.observer/filing/0001193125-24-283722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.